VA-GLA ID section has developed guidelines for issues encountered amongst our specific patient population. These guidelines have been tailored to the antimicrobial flora prevalent at VA-GLA and, as such, may not be applicable at other institutions.
Guidelines should not be viewed as rules of practice that require 100% compliance. Rather, they should be used to assist in clinical decision-making. Furthermore, guidelines may not be applicable to all patients. If questions or problems arise, then an ID consultant should be contacted.
GENERAL
• Is my patient getting better? What to expect regarding time frame for improvement in skin/soft tissue infections and pneumonia
• Guide to de-escalation of antipseudomonal therapy (2013)
RESPIRATORY CONDITIONS
• Influenza (2017-2018)
• Pneumonia (2019) (NEW)
• COVID-19 (NEW-updated 1-26-23)
BACTEREMIA AND ENDOCARDITIS
• Staphylococcus aureus bacteremia and infective endocarditis (2014)
OTHER BACTERIAL INFECTIONS
• Clostridium difficile infection (2018)
• Guide to gram positive infections (2013)
• Skin/soft tissue infection (2017) ANTIBIOTIC ALGORITHM FOR DIABETIC FOOT INFECTION ED DALBAVANCIN PROTOCOL
• Complicated urinary tract infection (2019) and Less Is More Algorithm for urine culture management (2019)
HIV EXPOSURE
• Occupational exposure to blood or body fluids (2023) (click HERE for trainee-specific guidelines)
• Non-occupational exposure (2020)
• HIV pre-exposure prophylaxis: National VA guidance GLA guidance for providers ID section operational guidance for injectables
DOXYCYCLINE SEXUALLY TRANSMITTED DISEASE PROPHYLAXIS (DOXYPEP) (2023)
ANTIBIOTIC USE
• Vancomycin dosing (2013)
• Vancomycin adverse event (2013)
• Aminoglycosides (including once daily administration)
• Polymyxin B, colistin use and dosing (2016)
• Use of ß-lactam agents in patients with history of allergy (2007)
MENINGOCOCCAL VACCINATION (2017)
PROPHYLAXIS
• Antibiotic prophylaxis for surgical procedures (2024)
• Antibiotic prophylaxis for transvascular hepatic chemoembolization (2008)
• Antibiotic prophylaxis for prostate biopsy (2022)